GlassScriptPhysician profile
Brian N Naftulin
NPI 1407977531
$2,510.55
in general payments reported to CMS, 2019-2025
20 companies · $44.33 in 2025
The $44.33 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $315 · 2021: $621 · 2022: $779 · 2023: $211 · 2024: $149 · 2025: $44.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $885.54 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $329.81 | 2019-2023 | Xiaflex, Aveed, Edex |
| Abbvie INC. | $278.27 | 2019-2022 | |
| Pfizer INC. | $228.35 | 2019-2023 | |
| Myriad Genetic Laboratories, INC. | $151.49 | 2023-2024 | Prolaris |
| Coloplast Corp | $138.33 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $78.64 | 2024 | Endosheath Technology, Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $74.06 | 2022 | |
| Boston Scientific Corporation | $52.54 | 2020-2022 | |
| Janssen Biotech, INC. | $40.09 | 2019-2021 | |
| Allergan, INC. | $38.63 | 2020-2022 | |
| Mindray Ds USA, INC. | $34.33 | 2021 | |
| Convatec INC. | $27.19 | 2025 | |
| Accord Healthcare, INC. | $24.50 | 2024 | |
| Sumitomo Pharma America, INC. | $24.40 | 2023 | Orgovyx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $24.21 | 2024 | |
| Antares Pharma, INC. | $22.56 | 2019 | |
| Mallinckrodt Enterprises LLC | $22.42 | 2019 | |
| Myovant Sciences INC. | $18.05 | 2022 | |
| Dentsply Ih Ab | $17.14 | 2025 | Lofric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Naftulin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.